MedPath

Molecular and Cellular Analysis of Breast Cancer

Suspended
Conditions
Breast - Female
Breast - Male
Registration Number
NCT02243397
Lead Sponsor
Stanford University
Brief Summary

The purpose of the study is to investigate the different types and subtypes of cells found in breast tumors. The investigators will do this using a variety of molecular analysis tools that may allow for improved tests. The different types of cells in breast cancer impacts the way individuals respond to various treatments.

Detailed Description

Not available

Recruitment & Eligibility

Status
SUSPENDED
Sex
Female
Target Recruitment
500
Inclusion Criteria
  1. Histologically proven diagnosis of breast cancer or a carcinoma of unknown primary consistent with the presentation of a primary breast malignancy.
  2. 18 years of age or older.
  3. Ability to understand and the willingness to sign a written informed consent do
Read More
Exclusion Criteria
  • None
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
levels of GM-CSF in plasma10 years

We will be measuring levels of GM-CSF (Granulocyte-macrophayge colony stimulating factor) from the plasma of the patient before during and after the irradiation treatment to study if there is any increase in the GM-CSF production

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Stanford University Cancer Institute

🇺🇸

Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath